These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36530095)

  • 1. Resource utilization and convalescent care cost in neonatal opioid withdrawal syndrome.
    Ronan K; Hughes Driscoll CA; Decker E; Gopalakrishnan M; El Metwally D
    J Neonatal Perinatal Med; 2023; 16(1):49-57. PubMed ID: 36530095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphine versus methadone for neonatal opioid withdrawal syndrome: a randomized controlled pilot study.
    Sutter MB; Watson H; Yonke N; Weitzen S; Leeman L
    BMC Pediatr; 2022 Jun; 22(1):345. PubMed ID: 35705944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of neonatal outcomes in pregnant women undergoing medication-assisted treatment of opioid use disorder with methadone or buprenorphine/naloxone.
    Petrich M; Battin M; Walker E; Brown M; Abdelwahab M; Ma'ayeh M; Rood KM
    J Matern Fetal Neonatal Med; 2022 Dec; 35(26):10481-10486. PubMed ID: 36202398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neonatal Opioid Withdrawal Syndrome: A Comparison of As-Needed Pharmacotherapy.
    Morrison TM; MacMillan KDL; Melvin P; Singh R; Murzycki J; Van Vleet MW; Rothstein R; O'Shea TF; Gupta M; Schiff DM; Wachman EM
    Hosp Pediatr; 2022 May; 12(5):530-538. PubMed ID: 35403199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing Neonatal Opioid Withdrawal Syndrome Severity as a Function of Maternal Buprenorphine Dose and Umbilical Cord Tissue Concentrations.
    Rana D; McLeod AR; Gaston PK; Hill DM; Pourcyrous M
    Ann Pharmacother; 2023 Aug; 57(8):892-898. PubMed ID: 36321504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neonatal Outcomes after Medications for Opioid Use Disorder during Pregnancy in a State Women's Prison Facility, 2016-2019.
    Knittel AK; Swartzwelder RA; Zarnick S; Tsujimoto TM; Horne T; Lin FC; Edwards J; Amos E; Alexander J; Thorp J; Jones HE
    J Addict Med; 2023 Sep-Oct 01; 17(5):587-591. PubMed ID: 37788614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effectiveness of opioid replacement agents for neonatal opioid withdrawal syndrome: a systematic review and meta-analysis.
    Lee JJ; Chen J; Eisler L; Li G; Davis JM; Sun LS
    J Perinatol; 2019 Nov; 39(11):1535-1545. PubMed ID: 31316147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design considerations for point-of-care clinical trials comparing methadone and buprenorphine treatment for opioid dependence in pregnancy and for neonatal abstinence syndrome.
    Winhusen T; Wilder C; Wexelblatt SL; Theobald J; Hall ES; Lewis D; Van Hook J; Marcotte M
    Contemp Clin Trials; 2014 Sep; 39(1):158-65. PubMed ID: 25183042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A retrospective study of length of hospital stay in infants treated for neonatal abstinence syndrome with methadone versus oral morphine preparations.
    Lainwala S; Brown ER; Weinschenk NP; Blackwell MT; Hagadorn JI
    Adv Neonatal Care; 2005 Oct; 5(5):265-72. PubMed ID: 16202968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Safety and Efficacy of Methadone vs Morphine for Treatment of Neonatal Abstinence Syndrome: A Randomized Clinical Trial.
    Davis JM; Shenberger J; Terrin N; Breeze JL; Hudak M; Wachman EM; Marro P; Oliveira EL; Harvey-Wilkes K; Czynski A; Engelhardt B; D'Apolito K; Bogen D; Lester B
    JAMA Pediatr; 2018 Aug; 172(8):741-748. PubMed ID: 29913015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Cohort Comparison of Buprenorphine versus Methadone Treatment for Neonatal Abstinence Syndrome.
    Hall ES; Isemann BT; Wexelblatt SL; Meinzen-Derr J; Wiles JR; Harvey S; Akinbi HT
    J Pediatr; 2016 Mar; 170():39-44.e1. PubMed ID: 26703873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal Abstinence Syndrome: Influence of a Combined Inpatient/Outpatient Methadone Treatment Regimen on the Average Length of Stay of a Medicaid NICU Population.
    Lee J; Hulman S; Musci M; Stang E
    Popul Health Manag; 2015 Oct; 18(5):392-7. PubMed ID: 25803316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Newborn Cry Acoustics in the Assessment of Neonatal Opioid Withdrawal Syndrome Using Machine Learning.
    Manigault AW; Sheinkopf SJ; Silverman HF; Lester BM
    JAMA Netw Open; 2022 Oct; 5(10):e2238783. PubMed ID: 36301544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfer Timing and the Length of Medication Weaning for Neonatal Opioid Withdrawal Syndrome.
    Botticello AL; Chen YL; Smith MG; Chung AF; Marchetta CM; McMahon M; Van Orden K; Sulter A; Weinstein L; Zalewitz J; O'Neill J
    Hosp Pediatr; 2023 Jun; 13(6):499-507. PubMed ID: 37183609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal abstinence syndrome after methadone or buprenorphine exposure.
    Jones HE; Kaltenbach K; Heil SH; Stine SM; Coyle MG; Arria AM; O'Grady KE; Selby P; Martin PR; Fischer G
    N Engl J Med; 2010 Dec; 363(24):2320-31. PubMed ID: 21142534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-discharge healthcare utilization in infants with neonatal opioid withdrawal syndrome.
    Shrestha S; Roberts MH; Maxwell JR; Leeman LM; Bakhireva LN
    Neurotoxicol Teratol; 2021; 86():106975. PubMed ID: 33766722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of Prescription Opioid Analgesics in Pregnancy and Risk of Neonatal Opioid Withdrawal Syndrome in Newborns.
    Esposito DB; Huybrechts KF; Werler MM; Straub L; Hernández-Díaz S; Mogun H; Bateman BT
    JAMA Netw Open; 2022 Aug; 5(8):e2228588. PubMed ID: 36001312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid Treatment for Neonatal Opioid Withdrawal Syndrome: Current Challenges and Future Approaches.
    McPhail BT; Emoto C; Butler D; Fukuda T; Akinbi H; Vinks AA
    J Clin Pharmacol; 2021 Jul; 61(7):857-870. PubMed ID: 33382111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antenatal methadone vs buprenorphine exposure and length of hospital stay in infants admitted to the intensive care unit with neonatal abstinence syndrome.
    Tolia VN; Murthy K; Bennett MM; Miller ES; Benjamin DK; Smith PB; Clark RH
    J Perinatol; 2018 Jan; 38(1):75-79. PubMed ID: 29048415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standard Fixed-Schedule Methadone Taper Versus Symptom-Triggered Methadone Approach for Treatment of Neonatal Opioid Withdrawal Syndrome.
    Wachman EM; Minear S; Hirashima M; Hansbury A; Hutton E; Shrestha H; Combs G; Barry K; Slater C; Stickney D; Walley AY
    Hosp Pediatr; 2019 Aug; 9(8):576-584. PubMed ID: 31270130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.